NORRIS MEDICINES LTD. Share Price

NORRIS MEDICINES LTD. Share Price

BSE: 524414
|
Pharmaceuticals
|
S Cap
₹ 14.75
+₹0.25 (1.72%)
1D
Last updated 03 Sep, 2026, 15:19 IST

NORRIS MEDICINES LTD. Share Price Today

As of 3 Sep 2026, NORRIS MEDICINES LTD. share price is ₹14.75. The stock opened at ₹15.22, compared to its previous close of ₹14.50. During today's trading session, NORRIS MEDICINES LTD. share price moved in the range of ₹14.08 to ₹15.22, with an average price of ₹14.65 for the day. Looking at its last 52-week, the stock has touched a low of ₹12.00 and a high of ₹19.63.

₹14.08
1.72% up today
₹15.22
1D LOW
1D HIGH

NORRIS MEDICINES LTD. Returns Calculator

Circuit
L
H
₹13.78
₹15.22
52-week
L
H
₹12.00
₹19.63

About NORRIS MEDICINES LTD.

NORRIS MEDICINES LTD. Share Price
ISIN
INE744C01029
Sector Market Cap
₹ 14.5 Cr

Norris Medicines Limited is an India-based company, which is focused on the health care industry. The Company is engaged in the manufacturing and exporting medicines and injections. The Company’s product categories include antibiotic, anti-inflammatory and analgesic range, G. I. range, dermatological range, nutrition range, anti-malaria, anti-emetic, cough/cold range, dental range, diabetics and cardiac, and miscellaneous range. Its antibiotic products include Arizon-100, Arizon-250, Arizon-500, Cefan-dry syurp, and Cefan DT-50. Its G.I. products include Denzym Syrup, Denzym Oral Drop, Ezynor-20, Regus-DSR, Sucrinor and Rinotac. Its dermatological products include Clobec-G, Gabax, Morfit Plus, Novadin-M, Silwon-C and Tioderm. Its nutrition products include Cand XP, Cand Fort, Can D suspension and Hemfit Plus Syrup. It has two plants situated at GIDC, Ankleshwar, Gujarat. Both the plants of the Company are World Health Organization Good Manufacturing Practices (WHO GMP) approved.

NORRIS MEDICINES LTD. Financial Highlights

  • Revenue: NORRIS MEDICINES LTD. reported revenue of ₹8.18 crore in FY26 vs ₹5.88 crore in FY25. It showed an increase of 39.12% on a yearly basis.
  • Operating Profit: NORRIS MEDICINES LTD. reported an operating loss of ₹0.28 crore in FY26 vs ₹1.18 crore in FY25. It showed an increase of 76.27% on a year-on-year basis.
  • Net Profit: NORRIS MEDICINES LTD. reported a net loss of ₹0.28 crore in FY26 vs ₹1.24 crore in FY25. It showed an increase of 77.42% on a yearly basis.

NORRIS MEDICINES LTD. Quarterly Result Highlights

  • NORRIS MEDICINES LTD. reported revenue of ₹0.92 crore in Jun 2026, compared with ₹1.43 crore in Mar 2026, representing a decrease of 35.66% on a quarter-on-quarter (QoQ) basis.
  • NORRIS MEDICINES LTD. reported an operating loss of ₹0.40 crore in Jun 2026, compared with ₹0.05 crore in Mar 2026, representing a decrease of 900.00% on a quarter-on-quarter (QoQ) basis.
  • NORRIS MEDICINES LTD. reported a loss of ₹0.40 crore in Jun 2026, compared with ₹0.05 crore in Mar 2026, reflecting a decrease of 900.00% on a QoQ basis.
  • The earnings per share (EPS) of NORRIS MEDICINES LTD. stood at ₹1.24 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
34.01%
FII
0.00%
Other DII
0.06%
Retail and other
65.92%
Mutual funds
0.01%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
14.50
P/E
-39.19
P/B
0.00
ROE
1.85%
D/E
-1.42
ROCE
3.44%
Div. Yield
0.00%
EPS(TTM)
-0.28
Turnover
0.59
EV/EBITDA
70.16
Net Margin
0.00%
Op. Margin
0.00%
ROA
-2.87%
Quick Ratio
0.00
Curr. Ratio
0.89
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Norris Medicines outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Norris Medicines appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,63,791.0038.285.5513.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,45,081.0083.7914.6215.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,90,351.0088.2922.6425.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,14,833.0025.004.2418.59%0.3117.35%237.300.09%0.3335.38
Cipla1,14,163.0034.023.3211.27%0.0014.95%423.360.92%0.4543.52
Laurus Labs1,00,660.0092.3218.9916.77%0.4016.14%97.200.11%0.6713.72
Lupin98,431.0017.734.3823.76%0.0424.88%659.000.84%0.57129.18
Dr. Reddy's Laboratories96,906.3030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Mankind Pharma98,304.7047.546.0311.74%0.3413.13%396.980.04%0.4449.37
Aurobindo Pharma95,299.8025.682.529.25%0.1911.76%394.820.24%0.3841.58

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

NORRIS MEDICINES LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹5.82₹5.64₹8.36₹9.44
Other Income₹0.06₹0.03₹0.01₹0.03
Total Revenue₹5.88₹5.66₹8.37₹9.46
Total Expenses₹7.06₹6.76₹9.57₹11.65
Profit Before Tax-₹1.18-₹1.10-₹1.19-₹2.18
Tax₹0.06₹0.09₹0.56₹1.08
Profit After Tax-₹1.24-₹1.19-₹1.75-₹3.26
EPS - Basic-₹1.24-₹1.19-₹1.75-₹3.26
EPS - Diluted-₹1.24-₹1.19-₹1.75-₹3.26

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹1.24-₹1.19-₹1.75-₹3.26
Income before WC changes-₹0.22-₹0.15₹0.92-₹0.06
Change in Assets-₹0.19-₹1.20-₹0.65₹3.96
Change in Liabilities₹0.92₹1.52₹0.92-₹4.91
Change in WC₹0.73₹0.32₹0.27-₹0.95
Cash flow from Operations₹0.51₹0.17₹1.20-₹1.01
Cash flow from Investing₹0.00₹0.05-₹0.02-₹0.09
Cash flow from Financing-₹0.50-₹0.20-₹1.18₹1.10
Total Cash Flow₹0.00₹0.02₹0.00₹0.00
Cash (Start of the year)₹0.04₹0.02₹0.02₹0.02
Cash (End of the year)₹0.04₹0.04₹0.02₹0.02

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹7.47₹8.04₹8.77₹9.92
Current Assets₹6.34₹6.14₹4.92₹4.27
Total Assets₹13.81₹14.19₹13.69₹14.19
Current Liabilities₹10.15₹9.23₹7.70₹6.78
Net Current Asset-₹3.81-₹3.08-₹2.78-₹2.51
Non-Current Liabilities₹18.53₹18.59₹18.43₹18.10
Equity Capital-₹14.87-₹13.63-₹12.44-₹10.69
Total Equity & Liabilities₹13.81₹14.19₹13.69₹14.19
* All values are in INR Crore
Qty
Bid
200
14.75
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 200
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
2
Neutral
5
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
41.48
Neutral
ATR (14)
0.63
Neutral
STOCH(9,6)
34.9
Neutral
STOCH RSI (14)
13.3
Bullish
ADX(9)
25.82
Bearish
UO(9)
46.02
Neutral
ROC(12)
-8.81
Bearish
WillR(14)
-74.13
Neutral
Period
Simple value
Exponential vaue
5D
15.01
14.86
10D
15.32
15.16
20D
15.43
15.33
50D
15.52
15.24
100D
14.76
14.98
Volume trend — traded volume by day
3 Sep0L
2 Sep0L
1 Sep0L
31 Aug0L
28 Aug0L
27 Aug0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
NORRIS MEDICINES LTD. Share Price
NORRIS MEDICINES LTD.
Pharmaceuticals
Add Stock
Add Another

NORRIS MEDICINES LTD. Share Price FAQs

NORRIS MEDICINES LTD. share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837